Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 1;27(3):597-612.
doi: 10.1212/CON.0000000000000956.

Acute Migraine Treatment

Jessica Ailani
Review

Acute Migraine Treatment

Jessica Ailani. Continuum (Minneap Minn). .

Abstract

Purpose of review: Migraine is a disabling disease of attacks of moderate to severe pain with associated symptoms. Every person with migraine requires treatment for acute attacks. Treatments can range from behavioral management and nonspecific medications to migraine-specific medications and neuromodulation. For many with migraine, having a combination of tools allows for effective treatment of all types of attacks.

Recent findings: Over the past several years, four neuromodulation devices have been cleared by the US Food and Drug Administration (FDA) for treatment of acute migraine, and three medications with novel mechanisms of action have been FDA approved. They add to the arsenal available to people with migraine and focus on migraine-specific pathways to allow for precise care with fewer side effects.

Summary: This article discusses acute migraine therapy, focusing on best-level evidence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41(7):646–657. doi:10.1046/j.1526-4610.2001.041007646.x - DOI
    1. Gallagher MR. What do patients want from acute migraine treatment?Cephalalgia 2004;24(S2):8–15. doi:10.1111/j.1468-2982.2004.00893.x - DOI
    1. Lipton RB, Fanning KM, Serrano D, et al. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 2015;84(7):688–695. doi:10.1212/WNL.0000000000001256 - DOI
    1. Buse DC, Nahas SJ, Schwedt TJ, et al. Acute treatment management gaps in people with migraine: results of the CaMEO study. Neurology 2020;94(S15).
    1. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 2015;55(1):21–34. doi:10.1111/head.12482 - DOI

LinkOut - more resources